Revenue
$146.1M
▲ 0.6% YoY
Net Income
-$196.0M
▼ 156.5% YoY
EPS
$-17.93
▼ 28.1% YoY
Cash
$60.5M
▼ 3.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Abate Kristin Chief Accounting Officer | Sell | Mar 2, 2026 | 559 | $9.41 | $5K | Form 4 ↗ |
Mano Michael EVP, CLO&Secretary | Sell | Mar 2, 2026 | 3.5K | $9.41 | $33K | Form 4 ↗ |
Cheng Sohanya Roshan EVP & Chief Commercial Officer | Sell | Mar 2, 2026 | 4.6K | $9.41 | $43K | Form 4 ↗ |
Rangwala Reshma EVP & Chief Medical Officer | Sell | Mar 2, 2026 | 5.1K | $9.41 | $48K | Form 4 ↗ |
Paulson Richard A. President and CEO | Sell | Mar 2, 2026 | 12.4K | $9.41 | $116K | Form 4 ↗ |
Poulton Stuart EVP, Chief Development Officer | Sell | Mar 2, 2026 | 5.1K | $9.41 | $48K | Form 4 ↗ |
Poulton Stuart EVP, Chief Development Officer | Sell | Feb 17, 2026 | 378 | $8.63 | $3K | Form 4 ↗ |
Paulson Richard A. President and CEO | Grant | Feb 5, 2026 | 81.1K | $0.00 | $0 | Form 4 ↗ |
Macomber Lori EVP, CFO & Treasurer | Sell | Feb 3, 2026 | 1.6K | $6.30 | $10K | Form 4 ↗ |
Cheng Sohanya Roshan EVP & Chief Commercial Officer | Grant | Jan 31, 2026 | 32.4K | $0.00 | $0 | Form 4 ↗ |
Rangwala Reshma EVP & Chief Medical Officer | Grant | Jan 31, 2026 | 32.4K | $0.00 | $0 | Form 4 ↗ |
Macomber Lori EVP, CFO & Treasurer | Grant | Jan 31, 2026 | 32.4K | $0.00 | $0 | Form 4 ↗ |